Clinical Trial Update: Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Hepatitis B immunoglobulin for chronic hepatitis B was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B immunoglobulin (Hepatitis B immune globulin)

Snippet

Sponsor: Hannover Medical School | Conditions: Chronic Hepatitis B | Phase 2 | Status: TERMINATED